P&G bets on health push with $3.8B Thorne deal

Procter & Gamble is buying supplement brand Thorne for $3.8 billion to accelerate growth of its health and wellness division. The deal follows Thorne’s long-running presence since 1984, its private-equity ownership in 2023, and more than $500 million in revenue in 2025, with the company expanding direct-to-consumer sales. P&G CEO Shailesh Jejurikar described Thorne as a well-run asset with potential to become a billion-dollar brand, as the acquisition moves toward formal announcement.